The abstract identifies tissue-specific networks that may underlie Mendelian disease phenotypes but doesn't explain the mechanistic basis for why the same genetic variant causes different phenotypes across tissues. Understanding these mechanisms is crucial for developing tissue-targeted therapies for neurogenetic disorders. Gap type: unexplained_observation Source paper: A reference map of the human binary protein interactome. (2020, Nature, PMID:32296183)
Landscape Summary: What molecular mechanisms drive tissue-specific phenotypes in Mendelian neurological diseases? is a 0.8 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.
Colonna, Sevlever, et al. (TREM2 biology)
What molecular mechanisms drive tissue-specific phenotypes in Mendelian neurological diseases? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: